Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Local drug delivery: current applications

S R Bailey1

  • 1University of Texas Health Science Center, Cardiac Catheterization Laboratory, San Antonio 78284-7872, USA.

Progress in Cardiovascular Diseases
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of breed differences in plasma adrenocorticotropic hormone concentrations among healthy horses and ponies.

Veterinary journal (London, England : 1997)·2023
Same author

Circannual variation in plasma adrenocorticotropic hormone concentrations and dexamethasone suppression test results in Standardbred horses, Andalusian horses and mixed-breed ponies.

Australian veterinary journal·2020
Same author

Effects of insulin on IGF-1 receptors in equine lamellar tissue in vitro.

Domestic animal endocrinology·2020
Same author

Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group.

Australian veterinary journal·2018
Same author

A pilot study to understand feasibility and acceptability of stool and cord blood sample collection for a large-scale longitudinal birth cohort.

BMC pregnancy and childbirth·2017
Same author

Incidence of laminitis and survey of dietary and management practices in pleasure horses and ponies in south-eastern Australia.

Australian veterinary journal·2017
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
Same journal

Circulating microRNA signatures associated with atrial remodeling in endurance athletes with PAFIYAMA syndrome: A case-control study.

Progress in cardiovascular diseases·2026
See all related articles

New catheter devices enable targeted drug delivery for coronary artery disease, overcoming limitations of systemic treatments. This approach aims for improved efficacy and reduced side effects in arterial interventions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Traditional catheter treatments for coronary artery disease focus on vessel expansion or ablation.
  • Recent advancements provide devices for precise, localized agent delivery to the arterial wall.
  • Prior systemic drug trials in humans showed limited efficacy and potential toxicity.

Purpose of the Study:

  • To review current catheter designs for localized treatment delivery.
  • To discuss ongoing trials of locally delivered agents and gene therapy for coronary artery disease.
  • To explore the understanding and future directions of targeted arterial treatment delivery.

Main Methods:

  • Review of current literature on catheter-based delivery systems.

Related Experiment Videos

  • Analysis of ongoing clinical trials for localized pharmacologic and gene therapy.
  • Discussion of challenges in achieving optimal delivery location and efficiency.

    • Main Results:

    • Emergence of novel catheter technologies for precise arterial wall treatment.
    • Ongoing investigations into locally delivered agents and gene therapy show promise.
    • Systemic drug delivery has been hampered by toxicity and lack of localized effect.

    Conclusions:

    • Localized catheter-based delivery represents a significant advancement in treating coronary artery disease.
    • Further research is needed to optimize delivery techniques and understand efficiency.
    • Targeted therapies hold potential for improved patient outcomes with reduced systemic risks.